Twist Bioscience (TWST) Competitors $47.94 +4.32 (+9.90%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends TWST vs. CTLT, PCVX, QGEN, ITCI, ROIV, ASND, RVMD, LNTH, LEGN, and NUVLShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Catalent (CTLT), Vaxcyte (PCVX), Qiagen (QGEN), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), Ascendis Pharma A/S (ASND), Revolution Medicines (RVMD), Lantheus (LNTH), Legend Biotech (LEGN), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. Twist Bioscience vs. Catalent Vaxcyte Qiagen Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Revolution Medicines Lantheus Legend Biotech Nuvalent Twist Bioscience (NASDAQ:TWST) and Catalent (NYSE:CTLT) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk, community ranking and dividends. Which has more volatility & risk, TWST or CTLT? Twist Bioscience has a beta of 1.82, suggesting that its share price is 82% more volatile than the S&P 500. Comparatively, Catalent has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Do analysts rate TWST or CTLT? Twist Bioscience currently has a consensus target price of $51.90, indicating a potential upside of 8.26%. Catalent has a consensus target price of $63.40, indicating a potential downside of 0.13%. Given Twist Bioscience's stronger consensus rating and higher possible upside, equities analysts clearly believe Twist Bioscience is more favorable than Catalent.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Catalent 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better earnings & valuation, TWST or CTLT? Twist Bioscience has higher earnings, but lower revenue than Catalent. Catalent is trading at a lower price-to-earnings ratio than Twist Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$312.97M9.09-$208.73M-$3.60-13.32Catalent$4.42B2.61-$1.04B-$2.26-28.09 Does the MarketBeat Community prefer TWST or CTLT? Catalent received 539 more outperform votes than Twist Bioscience when rated by MarketBeat users. However, 59.06% of users gave Twist Bioscience an outperform vote while only 57.71% of users gave Catalent an outperform vote. CompanyUnderperformOutperformTwist BioscienceOutperform Votes10159.06% Underperform Votes7040.94% CatalentOutperform Votes64057.71% Underperform Votes46942.29% Is TWST or CTLT more profitable? Catalent has a net margin of -9.28% compared to Twist Bioscience's net margin of -66.69%. Catalent's return on equity of -0.66% beat Twist Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-66.69% -32.27% -25.37% Catalent -9.28%-0.66%-0.24% Does the media favor TWST or CTLT? In the previous week, Catalent had 4 more articles in the media than Twist Bioscience. MarketBeat recorded 12 mentions for Catalent and 8 mentions for Twist Bioscience. Twist Bioscience's average media sentiment score of 0.59 beat Catalent's score of 0.46 indicating that Twist Bioscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Catalent 3 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryTwist Bioscience beats Catalent on 9 of the 16 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.59B$2.94B$5.12B$9.07BDividend YieldN/A1.90%4.91%4.22%P/E Ratio-13.3246.7391.3417.19Price / Sales9.09411.851,116.59116.80Price / CashN/A182.1042.6437.86Price / Book5.943.894.794.78Net Income-$208.73M-$42.21M$120.07M$225.60M7 Day Performance0.93%-2.14%-1.89%-1.24%1 Month Performance14.46%4.21%11.45%3.36%1 Year Performance32.54%18.40%30.61%16.58% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience2.5594 of 5 stars$47.94+9.9%$51.90+8.3%+36.7%$2.59B$312.97M-13.32990High Trading VolumeCTLTCatalent2.7788 of 5 stars$63.47+0.6%$63.40-0.1%N/A$11.52B$4.38B-27.9116,900High Trading VolumePCVXVaxcyte1.5995 of 5 stars$90.74+3.4%$147.50+62.6%+45.4%$11.31BN/A-19.07160Analyst ForecastInsider TradeQGENQiagen3.7415 of 5 stars$45.42+0.0%$51.15+12.6%+3.1%$10.36B$1.97B117.035,967ITCIIntra-Cellular Therapies4.0406 of 5 stars$84.52+1.8%$97.23+15.0%+27.8%$8.96B$612.78M-95.91560ROIVRoivant Sciences3.0012 of 5 stars$12.14+2.5%$17.93+47.7%+16.2%$8.84B$129.13M2.10860Insider TradeASNDAscendis Pharma A/S3.1403 of 5 stars$135.74+4.5%$191.77+41.3%+12.6%$8.23B$327.43M-16.52640RVMDRevolution Medicines4.5467 of 5 stars$44.89-0.3%$63.67+41.8%+71.5%$7.55B$11.58M-12.54443Insider TradeLNTHLantheus4.3768 of 5 stars$94.27+1.3%$130.00+37.9%+53.4%$6.55B$1.50B15.42834Analyst ForecastLEGNLegend Biotech1.553 of 5 stars$33.83-3.7%$81.54+141.0%-43.2%$6.18B$520.18M-36.971,800NUVLNuvalent2.1959 of 5 stars$86.65-0.2%$112.60+29.9%+16.9%$6.16BN/A-25.0340Insider TradeNews CoveragePositive News Related Companies and Tools Related Companies Catalent Alternatives Vaxcyte Alternatives Qiagen Alternatives Intra-Cellular Therapies Alternatives Roivant Sciences Alternatives Ascendis Pharma A/S Alternatives Revolution Medicines Alternatives Lantheus Alternatives Legend Biotech Alternatives Nuvalent Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TWST) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TWST Stock Alerts